CAND1.11: A Drug Target / Disease Biomarker (G100130460)

Target Name: CAND1.11

NCBI ID: G100130460

CAND1.11

Other Name(s): Uncharacterized LOC100130460 | uncharacterized LOC100130460

CAND1.11: A Drug Target / Disease Biomarker

CAND1.11 is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a member of the Candida family, which is known for their role in fungal infections. CAND1.11 has been shown to play a role in the regulation of cellular processes that are important for maintaining tissue health and function.

One of the key functions of CAND1.11 is its role in the regulation of the immune system. It has been shown to interact with various immune cells, including T cells and natural killer cells, and to play a role in the regulation of immune cell function. This suggests that CAND1.11 may be a potential drug target for the treatment of immune-related disorders.

In addition to its role in immune regulation, CAND1.11 has also been shown to play a role in the regulation of cell signaling pathways that are important for various cellular processes, including cell growth, apoptosis, and inflammation. This suggests that CAND1.11 may be a potential biomarker for the evaluation of cellular processes in diseases, such as cancer.

CAND1.11 has also been shown to play a role in the regulation of the blood-brain barrier, which is responsible for the exchange of nutrients, oxygen, and other substances between the brain and the bloodstream. This suggests that CAND1.11 may be a potential drug target for the treatment of disorders that involve disruption of the blood-brain barrier, such as Alzheimer's disease.

In conclusion, CAND1.11 is a protein that has been shown to play a role in a variety of cellular processes that are important for maintaining tissue health and function. As a result, it is a potential drug target for the treatment of a wide range of disorders. Further research is needed to fully understand the role of CAND1.11 in cellular processes and to develop effective treatments.

Protein Name: Uncharacterized LOC100130460

The "CAND1.11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAND1.11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets